The butter flavorant, diacetyl, exacerbates β-amyloid cytotoxicity

Chemical Research in Toxicology

Volumn 25, Issue 10, 2012, Pages 2083-2091

  More, Swati S ^a   Vartak, Ashish P ^a   Vince, Robert ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BUTANEDIONE; AMYLOID BETA PROTEIN[1-42]; ARGININE; GLYOXALASE; THIOFLAVINE;

ANIMAL CELL; ARTICLE; BETA SHEET; BLOOD BRAIN BARRIER; CIRCULAR DICHROISM; CYTOTOXICITY; DETOXIFICATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NONHUMAN; PROTEIN AGGREGATION; PROTEIN DEGRADATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BLOOD-BRAIN BARRIER; BUTTER; CELL LINE; CELL SURVIVAL; CIRCULAR DICHROISM; DIACETYL; DOGS; FLAVORING AGENTS; FLUORESCENT DYES; HUMANS; LACTOYLGLUTATHIONE LYASE; MADIN DARBY CANINE KIDNEY CELLS; PEPTIDE FRAGMENTS; PERMEABILITY; PROTEIN CONFORMATION; THIAZOLES;

EID: 84867534901     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx3001016     Document Type: Article

References (36)

1. Selkoe, D. J. (2000) Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-proteins Ann. N.Y. Acad. Sci. 924, 17-25
2. Brown, M. S., Ye, J., Rawson, R. B., and Goldstein, J. L. (2000) Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans Cell 100, 391-398
3. Wang, J., Dickson, D. W., Trojanowski, J. Q., and Lee, V. M. (1999) The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging Exp. Neurol. 158, 328-337
4. Hu, X., Crick, S. L., Bu, G., Freiden, C., Pappu, R. V., and Lee, J. M. (2008) Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide Proc. Natl. Acad. Sci. U.S.A. 106, 20324-20329
5. Brody, D. L., Magnoni, S., Schwetye, K. E., Spinner, M. I., Esparza, T. J., Stocchetti, N., Zipfel, G. J., and Holtzman, D. M. (2008) Amyloid-β dynamics correlate with neurological status in the injured human brain Science 321, 1221-1224
6. Tennent, G. A., Lovat, L. B., and Pepys, M. B. (1995) Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis Proc. Natl. Acad. Sci. U.S.A. 92, 4299-4303
7. Haass, C. and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid β-peptide Nature Rev. Mol. Cell. Biol. 8, 101-112
8. Heinitz, K., Beck, M., Schliebs, R., and Perez-Polo, J. R. (2006) Toxicity mediated by soluble oligomers of beta-amyloid (1-42) on cholinergic SN56.B5.G4 cells J. Neurochem. 98, 1930-1945
9. Ramasamy, R., Yan, S. F., and Schmidt, A. M. (2006) Methylglyoxal comes of AGE Cell 124, 258-260
10. Barrow, C. J., Uasuda, A., Kenny, P. T. M., and Zagorski, M. G. (1992) Solution conformations and aggregational proterties of synthetic amyloid β-peptides of Alzheimer's disease J. Mol. Biol. 225, 1075-1093
11. Jarrett, J. T. and Lansbury, P. T. J. (1993) Seeding "one- dimensional" crystallization of amyloid: A pathologic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058
12. Tjernberg, L. O., Naslund, J., Lundqvist, F., Johansson, J., Karlstrom, A. R., Thyberg, J., Terenius, L., and Nordstedt, C. (1996) Arrest of beta-amyloid fibril formation by a pentapeptide ligand J. Biol. Chem. 271, 8545-8548
13. Tjernberg, L. O., Callaway, D. J. E., Tjernberg, A., Hahne, S., Lilliehook, C., Terenius, L., Thyberg, J., and Nordstedt, C. (1999) A molecular model of Alzheimer Amyloid β- Peptide fibril formation J. Biol. Chem. 274 (18) 12619-12625
14. Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., and Cerami, A. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 91, 4766-4770
15. Dickerson, T. J. and Janda, K. D. (2003) Glycation of the amyloid β-protein by a nicotine metabolite: A fortituous chemical dynamic between smoking and Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 100, 8182-8187
16. Schrater, E. N. (2002) Popcorn worker's lung N. Engl. J. Med. 347, 360-361
17. Kreiss, K., Gomaa, A., Kullman, G., Fedan, K., Simoes, E. J., and Enright, P. L. (2002) Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant N. Engl. J. Med. 347, 330-338
18. Martyny, J. W., Van Dyke, M. V., Arbuckle, S., Towle, M., and Rose, C. S. (2008) Diacetyl exposures in the flavor manufacturing industry J. Occup. Environ. Hyg. 5, 679-688
19. LeVine, H, 3rd. (1993) Thioflavin T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution Protein Sci. 2, 404-410
20. Barrow, C. J., Yasuda, A., Kenny, P. T., and Zagorski, M. G. (1992) Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra J. Mol. Biol. 225, 1075-1093
21. Walker, J. M. The Protein Protocols Handbook; Humana Press: Totowa, NJ, 2002; pp 523-528.
22. Revel, G., Nicolau-Pripis, L., Barbe, J.-C., and Bertrand, A. (2000) The detection of α-dicarbonyl compounds in wine by formation of quinoxaline derivatives J. Sci. Food. Agric. 80, 102-108
23. Vince, R. and Wadd, W. B. (1969) Glyoxalase inhibitors as potential anticancer agents Biochem. Biophys. Res. Commun. 35, 593-598
24. More, S. S. and Vince, R. (2009) Inhibition of glyoxalase-I: The first low-nanomolar tight-binding inhibitors J. Med. Chem. 52, 4650-4656
25. Nichols, M. R., Moss, M. A., Reed, D. K., Cratic-McDaniel, S., Hoh, J. H., and Rosenberry, T. L. (2005) Amyloid-β protofibrils differ from amyloid-β aggregates induced in dilute hexafluoroisopropanol in stability and morphology J. Biol. Chem. 280, 2471-2480
26. Wood, S. J., Maleeff, B., Hart, T., and Wetzel, R. (1996) Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ J. Mol. Biol. 256, 870-877
27. Salomon, A. R., Marcinowski, K. J., Friedland, R. P., and Zagorski, M. G. (1996) Nicotine inhibits amyloid formation by the β-peptide Biochemistry 35, 13568-13578
28. Matthews, J. M., Watson, S. L., Snyder, R. W., Burgess, J. P., and Morgan, D. L. (2010) Reaction of the butter flavorant diacetyl (2,3-butanedione) with N-α-acetylarginine: A model for epitope formation with pulmonary proteins in the etiology of obliterative bronchiolitis J. Agric. Food. Chem. 58, 12761-12768
29. Gomes, R., Sousa, S. M., Quintas, A., Cordeiro, C., Freire, A., Pereira, P., Martins, A., Monteiro, E., Barroso, E., and Ponces, F. A. (2005) Argpyrimidine, a methylglyxosal-derived advanced glycation end-product in familial amyloidotic polyneuropathy Biochem. J. 385, 339-345
30. Li, Y. P., Bushnell, A. F., Lee, C. M., Perlmutter, L. S., and Wong, S. K. (1996) Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells Brain Res. 738, 196-204
31. Wang, Q., Rager, J. D., Weinstein, K., Kardos, P. S., Dobson, G. L., Li, J., and Hidalgo, I. J. (2005) Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier Int. J. Pharm. 288, 349-359
32. Naiki, H., Higuchi, K., Hosokawa, M., and Takeda, T. (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T Anal. Biochem. 177, 244-249
33. Krebs, M. R. H., Bromley, E. H. C., and Donald, A. M. (2005) The binding of thioflavin-T to amyloid fibrils:localisation and implications J. Struct. Biol. 149, 30-37
34. Khurana, R., Coleman, C., Ionescu-Zanetti, C., Carter, S. A., Krishna, V., Grover, R. K., Roy, R., and Singh, S. (2005) Mechanism of thioflavin T binding to amyloid fibrils J. Struct. Biol. 151, 229-238
35. Wang, Q., Rager, J. D., Weinstein, K., Kardos, P. S., Dobson, G. L., Li, J., and Hidalgo, I. J. (2005) Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier Int. J. Pharm. 288, 349-359
36. Lupidi, G., Bollettini, M., Venardi, G., Marmochi, F., and Rotilio, G. (2001) Functional residues on the enzyme active site of glyoxalase I from bovine brain Prep. Biochem. Biotechnol. 31, 317-329